Quantcast

Latest Ribbon symbolism Stories

2014-06-03 16:24:50

BRONX, N.Y., June 3, 2014 /PRNewswire-USNewswire/ -- A test that counts the number of locations in tumor specimens where tumor cells may invade blood vessels predicted the risk of distant spread, or metastasis, for the most common type of breast cancer. http://photos.prnewswire.com/prnvar/20140603/93895 The study was led by researchers at the National Cancer Institute (NCI)?designated Albert Einstein Cancer Center of Albert Einstein College of Medicine of Yeshiva University and...

2014-06-03 16:24:32

FAIRFAX, Va., June 3, 2014 /PRNewswire/ -- Nancy Cappello, Ph.D., Executive Director and Founder of Are You Dense, Inc., will join Fairfax Radiological Consultants to provide opening remarks at a special, invitation-only event this evening. Are You Dense (www.areyoudense.org) is an organization dedicated to informing the public about dense breast tissue and its significance for the early detection of breast cancer. The open house event will introduce local physicians and office...

2014-06-03 11:48:40

University of Colorado Denver At the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO), University of Colorado Cancer Center researchers reported results of a Phase I trial of OMP-54F28 (FZD8-Fc), an investigational drug candidate discovered by OncoMed Pharmaceuticals targeting cancer stem cells (CSCs). The drug was generally well tolerated, and several of the 26 patients with advanced solid tumors experienced stable disease for greater than six months. Three trials...

2014-06-03 08:32:24

Two Studies Presented at ASCO® Demonstrate Company's Ability to Develop Tests to Predict Disease Aggressiveness Across Various Cancers REDWOOD CITY, Calif., June 3, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of two studies demonstrating the ability of its Oncotype DX(®) test and a new 16-gene panel to predict disease aggressiveness and clinical outcomes in prostate and renal cancers, respectively. These results, presented at the American...

2014-06-03 08:32:20

First U.S. Installs of Next-generation Breast Imaging Technology at Fairfax Radiological Breast Diagnostic Imaging Center in D.C. and Phelps Memorial Hospital in NY MILWAUKEE, June 3, 2014 /PRNewswire/ -- GE Healthcare today announced FDA approval and the U.S. launch of their new breast imaging technology, the Invenia(TM) ABUS, proven to help clinicians find 35.7% more cancers in women with dense breasts than mammograms alone(1). In keeping with a strong commitment to furthering the...

2014-06-03 08:31:33

ROCKVILLE, Md., June 3, 2014 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, announced today that Franklin C. Salisbury, Jr. has joined the Company's Board of Directors. http://photos.prnewswire.com/prnvar/20010620/ENMDLOGO Since 1998, Mr. Salisbury has served as president of the National Foundation for Cancer Research (NFCR), an organization that supports healthcare...

2014-06-03 08:31:30

Pathway Analysis Confirms the Unique Clinical Utility of Caris Molecular Intelligence(TM) CHICAGO, June 3, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of precision medicine, announced today the presentation of data identifying multiple novel biomarkers as potential targets for immunotherapeutic agents in triple negative breast cancer (TNBC), an aggressive form of breast cancer in which the cancer cells lack estrogen receptors...

2014-06-02 23:01:34

New results from the National Health and Wellness Survey show non-adherence is associated with greater work and activity impairment. New York, NY (PRWEB) June 02, 2014 Nearly one in four women with breast cancer are non-adherent with their oral endocrine therapies, according to new findings from Kantar Health’s National Health and Wellness Survey (NHWS). The research will be presented today at the 19th Annual International Meeting for ISPOR (International Society for Pharmacoeconomics...

2014-06-02 16:26:24

OAKLAND, Calif., June 2, 2014 /PRNewswire/ -- Patients with specific HER2+ breast cancer tumors have a low risk of the cancer recurring five years after diagnosis, even without chemotherapy or treatment with a common antibody, according to a Kaiser Permanente study published in the Journal of Clinical Oncology. http://photos.prnewswire.com/prnvar/20130718/SF49717LOGO Researchers reviewed 16,975 cases of breast cancer diagnosed in Kaiser Permanente patients between 2000 and 2006....

2014-06-02 12:28:58

NEWPORT NEWS, Va., June 2, 2014 /PRNewswire/ -- When a health insurance company denies a claim, most people complain to their friends and family and then accept it, arranging payment methods or even denying themselves a procedure that may save their life. After all, what can one do to fight against the big insurers? http://photos.prnewswire.com/prnvar/20140528/91712 Plenty! When Karen Larson from Golden Valley Minnesota, received the news that her new health insurance did not...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related